Prescription of medicines for the aged: quality indicators, their instruments and measures as indispensable strategies in the health system

Authors

DOI:

https://doi.org/10.33448/rsd-v11i2.25942

Keywords:

Aged; Prescriptions; Drug Utilization; Inappropriate Prescribing; Quality indicators in health care.

Abstract

Drug therapy is an integral part of the aged care plan, and prescribing is a difficult and challenging process. Investigating the prescription of the aged is a practice recommended as a tool in the evaluation of the quality of the health service, since drug treatment is an essential element of clinical care for the aged, and the optimization of prescription is necessary, as it has become a worldwide important health problem. The present study aims to present and discuss the quality indicators of prescription in the aged and the use of instruments and measures as strategies for their appropriate use in the health system. The method used was the narrative review of the literature, through works already published, found in databases in Portuguese and English, to collaborate with the continuing education of health professionals and provide the rational and safe use of drug therapy. In view of the data presented, it is essential to promote a quality and adequate prescription so that the aged can have a better quality of life so that they can live as long as possible in their homes with health, autonomy and independence.

References

AGS. American Geriatrics Society. (2015) Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 63 (11): 2227-2246. 10.1111/jgs.13702.

AGS. American Geriatrics Society. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 67(4):674-694. 10.1111/jgs.15767.

Arruda, D. C. J., Eto, F. N., Velten, A. P. C., Morelato, R. L., & Oliveira E. R. A. (2015). Fatores associados a não adesão medicamentosa entre idosos de um ambulatório filantrópico do Espírito Santo. Rev. Bras. Geriatr. Gerontol, 18(2):327-337 https://doi.org/10.1590/1809-9823.2015.14074

Avorn, J. (2002). Inappropriate prescribing for elderly patients. JAMA. 287(10):1265.

Baldoni, A. de O., Chequer, F. M., Ferraz, E. R., Oliveira D, de P., Pereira, L. R. L., & Dorta, D. J. (2010). Elderly and drugs: risks and necessity of rational use. Braz. J. Pharm. Sci, 46(4): 617-631. https://doi.org/10.1590/S1984-82502010000400003

Baldoni, A. de O., & Pereira, L. R. L. (2011). The impact of Brazilian population aging on the health system from the perspective of pharmacoepidemiology: a narrative review. Rev Ciênc Farm Básica Apl, 32(3):313-321.

Baldoni, A. de O., Ayres, L. R., Martinez, E. Z., DewulfI, N. de L., dos Santos, V., Obreli-Neto, P. R., & Pereira, LR. L. (2013). Pharmacoepidemiological profile and polypharmacy indicators in elderly outpatients. Braz. J. Pharm. Sci, 49(3):443-452. https://doi.org/10.1590/S1984-82502013000300006

Baldoni, A. de O., Ayres. L. R., Martinez, E. Z., Dewulf. N. de L., Dos Santos, V., Pereira, L. R. L. (2014). Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. Int J Clin Pharm, 36(2):316-24. 10.1007/s11096-013-9880-y

Beers, M. H., Ouslander, J. G., Rollingher, I., Reuben, D. B., Brooks, J., & Beck, J. C. (1991). Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med, 151(9):1825-1832.

Beuscart, J. B., Dupont, C., Defebvre, M. M., & Puisieux, F. (2014). Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: a population based study in a French region. Arch Gerontol Geriatr, 59(3):630-5. 10.1016/j.archger.2014.08.006

Bjorkman, I. K., Fastbomm J., Schmidt, I. K., & Bernsten, C. B. (2002). Drug-drug interactions in the elderly. Ann Pharmacother, 36(11):1675-1681. 10.1345/aph.1A484

Borja-Oliveira, C. R. (2017). Effect of anticholinergic cognitive burden in the elderly – an integrative review. Estud Interdiscipl Envelhec, 22(2):57-74.

Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C. (2008). Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, 4(3): 311-320. https://doi.org/10.2217/1745509X.4.3.311

Brunton, l. l., Chabner, B. A., Knollmann, B. C. (2018). As Bases Farmacológicas da Terapêutica de Goodman e Gilman. Porto alegre: AMGH.

Campbell, N., Boustani, M., Limbil, T., Ott, C., Fox, C., Maidment, I., Schubert, C. C., Munger, S., Fick, D., Miller, D., & Gulati, R. (2009). The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging, 4:225-33. 10.2147/cia.s5358

Cardwell, K., Hughes, C. M., & Ryan, C. (2015). The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature. Drugs Aging, 32(10):835-48. 10.1007/s40266-015-0310-9

Carnahan, R. M., Lund, B. C., Perry, P. J., Pollock, B. G., & Culp, K. R. (2006). The Anticholinergic Drug Scale as a Measure of Drug-Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity. J Clin Pharmacol, 46(12):1481-1486. 10.1177/0091270006292126

Carvalho, M. F. C., Romano-Lieber, N. S., Bergsten-Mendes, G., Secoli, S. R., Ribeiro, E., Lebrão, M. L. & Duarte, Y. A. O. (2012). Polifarmácia entre idosos do Município de São Paulo – estudo SABE. Revista Brasileira de Epidemiologia, 15(4): 817-27. https://doi.org/10.1590/S1415-790X2012000400013

Casarin, S. T., Porto, A. R., Gabatz, R. I. B., Bonow, C. A., Ribeiro, J. P., & Mota, M. S. (2020). Tipos de revisão de literatura: considerações das editoras do Journal of Nursing and Health / Types of literature review: considerations of the editors of the Journal of Nursing and Health. Journal of Nursing and Health, 10(5), 1–7. https://doi.org/10.15210/jonah.v10i5.19924

Castellar, J. I., Karnikowski, M. G. O., Vianna, L. G., & Nóbrega, O. T. (2007). Estudo da farmacoterapia prescrita a idosos em instituição brasileira de longa permanência. Acta Med Port, 20: 97-105.

Castilho, E. C., Reis, A. M., Borges, T. L., Siqueira, L. D., & Miasso, A. (2018). Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. J Psychiatr Ment Health Nurs, 25(1):3-13. 10.1111/jpm.12431

Correr, C. J., Pontarolo, R., Ferreira, L. C., & Baptistão, A. S. (2007). Drug-related problems risks in patients of a geriatric institution. Rev Farm Bioquim Univ Sao Paulo, 43(1):55-62.

Correr, C. J., Otuki, M. F., & Soler, O. (2011). Assistência farmacêutica integrada ao processo de cuidado em saúde: gestão clínica do medicamento. Revista Pan-Amazônica de Saúde, 2(3).41-9. http://dx.doi.org/10.5123/S2176-62232011000300006

Correr, C. J., & Otuki, M. F. (2013). A prática farmacêutica na farmácia comunitária. Porto Alegre: Artmed.

Côrrea, J., Lorenz, C., & Colet, C. F. (2017). Comparação entre estratégias de farmacovigilância hospitalar nos países da américa latina. Revista Contexto & Saúde, 17(33): 155-166. http://dx.doi.org/10.21527/2176-7114.2017.33.155-166

Costa, R. Me., Lima, V. A. B., Paiva, I. G., Sousa, P. T. P., & Lima, L. G. (2008). Use of medicines among elderly people. Geriatr Gerontol Aging. 2:126-131.

Costa, S. C., E& Pedroso, E. R. P. (2011). A prescrição de medicamentos para idosos internados em serviço de clínica médica: atualização. Rev Med Minas Gerais, 21(2): 201-214.

Diaz, R. B. (2002). Adesão ao tratamento medicamentoso em pacientes Idosos. In: M.P. Netto (Ed.), Gerontologia: a velhice e o envelhecimento em visão global (230-241p). São Paulo: Atheneu.

Dimitrow, M. S., Airaksinen, M. S., Kivelä, S. L., Lyles, A., & Leikola, S. N. (2011). Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc, 59(8):1521-30. 10.1111/j.1532-5415.2011.03497.x.

Doron, G., Birkan, I., & Gulistan, B. (2015). Routine deprescribing of chronic medications to combat polypharmacy. Therapeutic advances in drug safety, 6(6):212-233. 10.1177/2042098615613984

Durán, C., AzermaI, M., Vander, & Stichele, R. (2013). Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol; 69(7):1485-1496. 10.1007/s00228-013-1499-3

Fialová, D., Topinková, E., Gambassi, G., Finne-Soveri, H., Jónsson, P. V., Carpenter, I., Schroll, M., Onder, G., Sorbye, L. W., Wagner, C., Reissigová, J., Bernabei, R., & AdHOC Project Research Group. (2005). Potentially inappropriate medication use among elderly home care patients in Europe. JAMA, 293(11):1348-58. 10.1001/jama.293.11.1348.

Franceschet-de-Sousa, I., Biscaro, A., Biscaro, F., & Fernandes, M. S. (2010) Uso Racional de Medicamentos: Relato de Experiência no Ensino Médico da Unesc, Criciúma/SC. Revista Brasileira de Educação Médica, 34 (3) : 438 – 445. https://doi.org/10.1590/S0100-55022010000300014

Freitas, P. E. F., & Reis, A. M. M. (2018). Prescrição inapropriada de medicamentos a idosos: análise dos critérios publicados de 2011 a 2016. Rev. Bras. Farm. Hosp. Serv. Saúde, 8(4): 31-36. 10.30968/rbfhss.2017.084.006

Fox, C., Smith, T., Maidment, I., Chan, W. Y., Bua, N., Myint, P. K., Boustani, M., Kwok, C. S., Glover, M., Koopmans, I., & Campbell, N. (2014). Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing, 43(5):604-615. 10.1093/ageing/afu096

Fulton, M. M., & Allen, E. R. (2005). Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract, 17(4):123-132. 10.1111/j.1041-2972.2005.0020.x.

Fustinoni, S., Renard, D., Santos-Eggimann, B., & Seematter-Bagnoud, L. (2015). Polypharmacy and associated factors among community-dwelling older persons in a Swiss Canton. Clinical Therapeutics, 37(8): e39-e40. https://doi.org/10.1016/j.clinthera.2015.05.119

Gallagher, P. F., Barry, P. J., Ryan, C., Hartigan, I., & O'Mahony, D. (2008). Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing, 37 (1): 96-101. 10.1093/ageing/afm116

Galvão, M. P. A., & Ferreira, M. B. C. (2006). Prescrição de medicamentos em geriatria. In: Fuchs, F.D., Wannmacher, L., Ferreira, M.B.C. (Eds), Farmacologia clínica: fundamentos da terapêutica racional. (3a ed. 1096p), Rio de Janeiro: Guanabara Koogan.

Gerretsen, P., & Pollock, B. G. (2011). Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin Drug Saf, 10(5):751-65. 10.1517/14740338.2011.579899

Gerretsen, P., & Pollock, B. G. (2013). Cognitive risks of anticholinergics in the elderly. Aging Health, 9(2):159–166. https://doi.org/10.2217/ahe.13.14

Gorzoni, M. L., Fabbri, R. M. A., & Pires, S. L. (2012). Potentially inappropriate medications in elderly. Revista da Associação Médica Brasileira, 58(4): 442-446. https://doi.org/10.1590/S0104-42302012000400014

Gorzoni, M. L., & Fabri, R. M. (2017). Applicability of Anticholinergic Risk Scale in hospitalized elderly persons. Thematic Section - Drug Use and Associated Risks Among the Elderly. Rev. bras. geriatr. Gerontol, 20(1):123-128. https://doi.org/10.1590/1981-22562017020.150191

Guaraldo, L., Cano, F. G., Damasceno, G. S., & Rozenfeld, S. (2011). Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr, 11:79. 10.1186/1471-2318-11-79

Guthrie, B., Makubate, B., Hernandez-Santiago, V., & Dreischulte, T. (2015). The rising tide of polypharmacy and drug-drug interactions: Population database analysis 1995-2010. BMC Med, 13(1):74. 10.1186/s12916-015-0322-7

Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., & Bates, D. W. (2003) Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting. JAMA, 289(9):1107–16. 10.1001/jama.289.9.1107. PMID: 12622580

Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(3):533-543.

Hori, K., Konishi, K., Tani, M., Tomioka, H., Akita, R., Kitajima, Y., Aoki, M., Yokoyama, S., Azuma, K., Ikuse, D., Akashi, N., Hosoi, M., Jinbo, K., & Hachisu, M. (2014). Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease. Disease markers, 459013. https://doi.org/10.1155/2014/459013

Hsu, W. H., Wen, Y. W., Chen, L. K., & Hsiao, F. Y. (2017). Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes. Ann Fam Med, 15(6):561-569. 10.1370/afm.2131

Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham, B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., Abernethy, D. R., & Health ABC Study. (2009). Drug burden index score and functional decline in older people. Am J Med, 122(12):1142-9 e1-2. 10.1016/j.amjmed.2009.02.021

Institute for Safe Medication Practices Canada. (2018). Deprescribing: Managing Medications to Reduce Polypharmacy. ISMP Canada Safety Bulletin, 18(3):1-6.

Junius-Walker, U., Theile, G., & Hummers-Pradier, E. (2007). Prevalence and predictors of polypharmacy among older primary care patients in Germany. Family Practice, 24(1):14-19. 10.1093/fampra/cml067

Kashyap, M., Belleville, S., Mulsant, B. H., Hilmer, S. N., Paquette, A., Tu, l., & Tannenbaum, C. (2014). Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. Journal of the American Geriatrics Society, 62(2), 336–341. https://doi.org/10.1111/jgs.12632

Kaufmann, C. P., Tremp, R., Hersberger, K. E., & Lampert, M. L. (2014). Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 70(1):1-11. 10.1007/s00228-013-1575-8

Kim, H. A., Shin, J. Y., Kim, M. H., & Park, B. J. (2014). Prevalence and predictors of polypharmacy among Korean elderly. PLoS One, 9(6): e98043. 10.1371/journal.pone.0098043

Lai, S. W., Liao, K. F., Liao, C. C., Muo, C. H., Liu, C. S., & Sung, F. C. (2010). Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore), 89(5):295-309. 10.1097/MD.0b013e3181f15efc

Landi, F., Dell'Aquila, G., Collamati, A., Martone, A.M., Zuliani, G., Gasperini, B., Eusebi, P., Lattanzio, F., & Cherubini, A. (2014). Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc, 15(11):825-829. 10.1016/j.jamda.2014.08.002.

Lertxundi, U., Domingo-Echaburu, S., Hernandez, R., Peral, J., & Medrano, J. (2013). Expert-based drug lists to measure anticholinergic burden: similar names, different results. Psychogeriatrics, 13(1):17-24. 10.1111/j.1479-8301.2012.00418.x.

Locatelli, J. (2007). Interações medicamentosas em idosos hospitalizados. Einstein, 5(4):343-346.

Lira, C. B. C., & de Oliveira, V. M. (2021). A importância da conciliação medicamentosa na prática da farmácia clínica em hospitais. Brazilian Journal of Development, 7(9): 89345-89355. 10.34117/bjdv7n9-207

Lyra Jr, D. P., Oliveira, A. T. C., Lima, K. S. L., Neves, S. J. F., Rocha, C. E., Oliveira, M. A. C., Lima, K. S. Q., Neves, S. J. F., Rocha, C. E., & Santana, D. P. (2002). Atenção Farmacêutica na dispensação de prescrições médicas. Infarma, 14 (11/12): 43-45.

Lyra Jr, D. P., Prado, M. C. T. A., Abriata, J. P., & Pelá, I. R. (2004). As Prescrições Médicas como Causadoras de Risco para Problemas Relacionados com os Medicamentos. Seguimento Farmacoterapêutico. Pharmacy Practice, 2(2):86-96.

Lu, C. J., & Tune, L. E. (2003). Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry, 11(4):458- 461.

Lu, W. H., Wen, Y. W., Chen, L. K.,& Hsiao, F. Y. (2015). Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ, 187(4):130-137. 10.1503/cmaj.141219

Lucchetti, G., & Lucchetti, A. L. (2017). Inappropriate prescribing in older persons: a systematic review of medications available in diferente criteria. Arch Gerontol Geriatr, 68:55–61. 10.1016/j.archger.2016.09.003

Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in elderly people. Lancet, 370(9582): 185–91. 10.1016/S0140-6736(07)61092-7

Malta, D. C., Bernal, R. T. I., Lima, M. G., Araújo, S. S. C., Silva, M. M. A., Freitas, M. I. F., & Barros, M. B. A. (2017). Doenças crônicas não transmissíveis e a utilização de serviços de saúde: análise da Pesquisa Nacional de Saúde no Brasil. Rev Saúde Publica. 2017; 51(1): 1s-4s. https://doi.org/10.1590/S1518-8787.2017051000090

Marques J. B. V., & Freitas, D. (2018). Método DELPHI: caracterização e potencialidades na pesquisa em Educação. Revista Pro.Posições, 29 (2): 389-415. https://doi.org/10.1590/1980-6248-2015-0140

Manso, M. E. G., Biffi, E. C. A., & Gerardi, T. J. (2015). Prescrição inadequada de medicamentos a idosos portadores de doenças crônicas em um plano de saúde no município de São Paulo, Brasil. Rev. Bras. Geriatr. Gerontol, 18(1):151-164. http://dx.doi.org/10.1590/1809-9823.2015.14056

Marengoni, A., Angleman, S., Melis, R., Mangialasche, F. K. A., Garmen, A., Meinow, B., & Fratiglioni, L. (2011). Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev, 10(4):430-9. 10.1016/j.arr.2011.03.003.

Mayer, T., Haefeli, W. E., & Seidling, H. M. (2015). Different methods, different results-how do available methods link a patient's anticholinergic load with adverse outcomes? Eur J Clin Pharmacol, 71(11):1299-314. 10.1007/s00228-015-1932-x

McGrath, K., Hajjar, E. R., Kumar, C., Hwang, C., & Salzman, B. (2017). Deprescribing: A simple method for reducing polypharmacy. J Fam Pract, 66(7):436-445.

Mercadante, A. C. C., Conti, M. S. B., Wagner, G. A., Andreoni, S. & Ramos, L. R. (2021). Fatores determinantes da polifarmácia entre idosos residentes em um grande centro urbano da região sudeste do brasil. Revista Valore, 6: 167-182, 2021. https://doi.org/10.22408/reva6020211027167-182

Myint, P. K., Fox, C., Kwok, C. S., Luben, R. N., Wareham, N. J., Khaw, K. T. (2015). Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21 636 middle aged and older men and women of EPIC-Norfolk prospective population study. Age Ageing. 2015; 44: 219-25. 10.1093/ageing/afu185

Nery, R. T., & Reis, A. M. M. (2019). Desenvolvimento de uma escala brasileira de medicamentos com atividade anticolinérgica. Einstein, 17(2):1-8. 10.31744/einstein_journal/2019AO4435

Oliveira, M. G., Amorim, W. W., Oliveira, C. R. B., Coqueiro, H. L., Gusmão, L. C., & Passos, L. C. (2016). Consenso Brasileiro De Medicamentos Potencialmente Inapropriados Para Idosos. Geriatr Gerontol Aging, 4:1-14.

O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P. (2015). STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing, 44(2):213-218. 10.1093/ageing/afu145.

Onder, G., Pedone, C., Landi, F., Cesari, M., Della Vedova, C., Bernabei, R., & Gambassi, G. (2002). Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc, 50(12):1962-1968. 10.1046/j.1532-5415.2002.50607.x.

Onder, G., Landi, F., Cesari, M., Gambassi, G., Carbonin, P., Bernabei, R., & Investigators of the GIFA Study. (2003). Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the elderly. Eur J Clin Pharmacol. 59 (2): 157-62. 10.1007/s00228-003-0600-8

Passarelli, M. C., Jacob-Filho, W., & Figueras, A. (2005). Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging, 22(9):767-77. 10.2165/00002512-200522090-00005

Pasina, L., Djade, C. D., Lucca, U., Nobili, A., Tettamanti, M., Franchi, C., Salerno, F., Corrao, S., Marengoni, A., Iorio, A., Marcucci, M., Violi, F. & Mannucci, P. M. (2013). Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging, 30(2):103-112. 10.1007/s40266-012-0044-x

Penteado, P. T. P. S., Cunico, C., Oliveira, K. S., Polichuk, M. O. (2002). O uso de Medicamentos por idosos. Visão Acadêmica, 3(1): 35-42. http://dx.doi.org/10.5380/acd.v3i1.498

Pereira, L. R. L., Vecchi, L. U. P., Baptista, M. E. C., & Carvalho, D. (2004). Avaliação da utilização de medicamentos em pacientes idosos por meio de conceitos de farmacoepidemiologia e farmacovigilância. Ciência & Saúde Coletiva, 9(2): 479-481. https://doi.org/10.1590/S1413-81232004000200023

Pereira, K. G., Peres, M. A., Iop, D., Boing, A. C., Boing, A. F., Aziz, M., & d’Orsi, E. (2017). Polifarmácia em idosos: um estudo de base populacional. Rev Bras Epidemiol, 20(2):335–344. https://doi.org/10.1590/1980-5497201700020013

Persaud, M., Holroyd-Leduc, J. M. (2014). Anticholinergic medications in the older adult: A hidden burden. Journal of the Canadian Geriatrics Society, 4(2): 4–7.

Pont, L. G., Nielen, J. T., McLachlan, A., Gnjidic, D., & Chan, L. (2015). Cumming RG, Taxis K. Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures. Br J Clin Pharmacol, 80(5):1169- 1175. 10.1111/bcp.12670

Portela, A. S., Simões, M. O. S., Fook, S. M. L., Montenegro Neto, A. N., & Silva, P. C. D. (2010). Prescrição médica: orientações adequadas para o uso de medicamentos? Ciência & Saúde Coletiva, 15(3):3523-3528. https://doi.org/10.1590/S1413-81232010000900027

Praxedes, M. F. S., Telles, P. C. P., & Filho Pinheiro, M. L. P. (2011). Identificação e análise de prescrições de medicamentos potencialmente inapropriados para idosos em uma Instituição Hospitalar. Cienc Cuid Saúde, 10(2):338-44. https://doi.org/10.4025/ciencuidsaude.v10i2.10214

Praxedes, M. F. S., Pereira, G. C. S., Lima, C. F. M., Santos, D. B., & Berhends, J. S. (2021). Prescrição de medicamentos potencialmente inapropriados para idosos segundo os Critérios de Beers: revisão sistemática. Ciência & Saúde Coletiva, 26(8):3209-3219. 10.1590/1413-81232021268.05672020

Rang, H. P., Dale, M. M., Flower, R. J., & Henderson, G. (2012). Rang & Dale’s Pharmacology. Elsevie.

Ramos, L. R. (2003). Determinant factors for healthy aging among senior citizens in a large city: the Epidoso Project in São Paulo. Cad. Saúde Pública, 19 (3): 793-798. https://doi.org/10.1590/S0102-311X2003000300011

Ramos, L. R., Tavares, N. U. L., Bertoldi, A. D., Farias, M. R., Oliveira, M. A., Luiza, V. L., Dal Pizzol, T. S., Arrais, P. S. D., &Mengue, S. S. (2016). Polypharmacy and Polymorbidity in Older Adults in Brazil: a public health challenge. Rev Saúde Pública, 50(2):1s-9s. https://doi.org/10.1590/S1518-8787.2016050006145

Reich, O., Rosemann, T., Rapold, R., Blozik, E., & Senn, O. (2014). Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization. PLoS One, 9(8):23–5. 10.1371/journal.pone.0105425.

Ribeiro, A. Q., Araújo, C. M. C., Acurcio, F. A., Magalhães, S. M. S., & Chaimowicz, F. (2005). Qualidade do uso de medicamentos por idosos: uma revisão dos métodos de avaliação disponíveis. Ciência & Saúde Coletiva, 10 (4): 1037-45. https://doi.org/10.1590/S1413-81232005000400026

Rocha, C. H., Oliveira, A. P. S., Ferreira, C., Faggiani, F. T., Schroeter, G., Souza, A. C. A., DeCarli, G. A., Morrone, F. B., & Werlang, M. C. (2008). Adesão à prescrição médica em idosos de Porto Alegre, RS. Revista Ciência & Saúde Coletiva, 13: 702-710. https://doi.org/10.1590/S1413-81232008000700020

Rochon, P. A., &Gurwitz, J. H. (1995). Drug therapy. Lancet, 346 (8966): 32-6. 10.1016/s0140-6736(95)92656-9

Rochon, P. A., Petrovic, M., Cherubini, A., Onder, G., O’Mahony, D., Sternberg, S. A., Stall, N. M., & Gurwitz, J. H. (2021). Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev, 2(5): E290 -E300. https://doi.org/10.1016/S2666-7568(21)00054-4

Rothberg, M. B., Pekow, P. S., Liu, F., Korc-Grodzicki, B., Brennan, M. J., Bellantonio, S., Heelon, M., & Lindenauer, P. K. (2008). Potentially Inappropriate Medication Use in Hopitalized Elders. J Hosp Med, 3(2):91-102. 10.1002/jhm.290

Rother, E. T. (2007). Revisão sistemática X revisão narrativa. Acta paul. Enferm, 20 (2). https://doi.org/10.1590/S0103-21002007000200001

Rovers, J. P., & Currie, J. D. (2010). Guia Prático da Atenção Farmacêutica: Manual de Habilidades Clínicas. São Paulo: Pharmabooks.

Rozenfeld, S. (2003). Prevalência, fatores associados e mau uso de medicamentos entre os idosos: uma revisão. Cadernos de Saúde Pública, 19(3): 717-724. https://doi.org/10.1590/S0102-311X2003000300004

Rudd, K. M., Raehl, C. L., Bond, C. A., Abbruscato, T. J., & Stenhouse, A. C. (2005). Methods for assessing drug-related anticholinergic activity. Pharmacotherapy, 25(11):1592-601. 10.1592/phco.2005.25.11.1592

Rudolph, J. L., Salow, M. J., Angelini, M. C., & McGlinchey, R. E. (2008). The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med, 168(5):508-513. 10.1001/archinternmed.2007.106

Ruxton, K., Woodman, R., & Mangoni, A. (2015). Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta- analysis. Br J Clin Pharmacol, 80(2):209-220. 10.1111/bcp.12617

Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015). Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatrics, 15(31):1-14. 10.1186/s12877-015-0029-9

Scott, I., & Jayathissa, S. (2010). Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J, 40(1):7-18. 10.1111/j.1445-5994.2009.02040.x.

Secoli, S. R. (2010). Polifarmácia: interações e reações adversas no uso de medicamentos por idosos. Rev Bras Enferm, 63(1): 136-40. https://doi.org/10.1590/S0034-71672010000100023

Shah, B. M., & Hajjar, E. R. (2012). Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med, 28(2):173-86. 10.1016/j.cger.2012.01.002

Shekelle, P. G., MacLean, C. H., Morton, S. C., & Wenger, N. S. (2001). Acove quality indicators. Ann Intern Med, 135(8 Pt 2):653-667. 10.7326/0003-4819-135-8_part_2-200110161-00004

Silva, A. L., Ribeiro, A. Q., Klein, C. H. & Acurcio, F. A. (2012). Utilização de medicamentos por idosos brasileiros, de acordo com a faixa etária: um inquérito postal. Cad. Saúde Pública, 28(6):1033-1045. https://doi.org/10.1590/S0102-311X2012000600003

Silva, R. N. P., Santos, T. G. O., & Lima, J. A. V. (2018). Uso racional de medicamentos: vantagens, desafios e perspectivas. Rev. Saberes daFSP/SP. 8 (2): 1-10.

Sousa-Muñoz, R. L., Ibiapina, G. R., Gadelha, C. S., & Maroja, J. L. S. (2012). Prescrições geriátricas inapropriadas e polifarmacoterapia em enfermarias de clínica médica de um Hospital-Escola. Rev. Bras. Geriatr. Gerontol, 15(2):315-323. https://doi.org/10.1590/S1809-98232012000200014

Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimized? Lancet, ;370 (9582):173-184. 10.1016/S0140-6736(07)61091-5

Steinman, M. A., & Hanlon, J. T. (2010). Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA, 304 (14):1592-601. 10.1001/jama.2010.1482

Vasconcelos, A. M. N., & Gomes, M. M. F. (2012). Transição demográfica: a experiência brasileira. Epidemiologia e Serviços de Saúde, 21(4): 539-548. https://dx.doi.org/10.5123/S1679-49742012000400003

Veras, R. (2009). Envelhecimento populacional contemporâneo: demandas, desafios e inovações. Rev. Saúde Pública, 43 (3): 548-554. https://doi.org/10.1590/S0034-89102009005000025

Veras, R. P. & Oliveira, M. (2018). Envelhecer no brasil: A construção de um modelo de cuidado. Revista Ciência & Saúde Coletiva, 23 (6): 1929-1936. 10.1590/1413-81232018236.04722018

Vuyk, J. (2003). Pharmacodynamics in the elderly. Best Pract Res Clin Anaesthesiol, 17(2):207-218. 10.1016/s1521-6896(03)00008-9.

Teixeira, J. J. V., & Lefévre, F. (2001). Drug prescription from the perspective of elderly patients. Rev Saúde Pública, 35(2):207-213. https://doi.org/10.1590/S0034-89102001000200016.

Yamagata, A. T., Júnior, R. M. C. B., Galato, D., Meiners, M. M. M. A., & Silva, E. V. (2018). Profile of studies of potential drug interactions in brazilian hospitals: an integrative review of the literature. Rev Bras Farm Hosp Serv Saude, 9(4): 1-9. 10.30968/rbfhss.2018.094.003

Wan-Hsuan, L., Yu-Wen, W., Liang-Kung, C., & Fei-Yuan, H. (2015). Effect of polypharmacy, potentially inapropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ, 187(4): 1369–1376. 10.1503/cmaj.141219.

Wannmacher, L. (2006). Medicamentos essenciais: vantagens de trabalhar com este contexto. Organização Pan-Americana da Saúde (OPAS): Uso racional de medicamentos. Temas selecionados, 3 (2): 1-6. Retrieved:2021, from: https://www.paho.org/bra/dmdocuments/HSE_URM_MEE_0106.pdf

Wawruch, M., Zikavska, M., Wsolova, L., Kuzelova, M., Tisonova, J., Gajdosik, J., Urbanek,K., & Kristova, V. (2008). Polypharmacy in elderly hospitalised patients in Slovakia. Pharm World Sci, 30 (3): 235-42. 10.1007/s11096-007-9166-3

Wehling, M. (2009). Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc, 57(3):560-1.

Willcox, S. M., Himmelstein, D. U., & Woolhandler, S. (1994). Inappropriate drug prescribing for the community-dwelling elderly. JAMA, 272(4):292-6.

World Health Organization. (1987). The Rational Use of Drugs. Report of the Conference of Experts. World Health Organization [WHO]. Retrieved 2021, from: https://apps.who.int/medicinedocs/en/m/abstract/Js17054e/

World Health Organization. (2002). Promoción del uso racional de medicamentos: componentes centrales Perspectivas Politicas sobre medicamentos en la OMS. World Health Organization [WHO]. Retrieved: 2021, from: https://apps.who.int/medicinedocs/en/d/Js4874s/

Published

05/02/2022

How to Cite

CONTI, M. de S. B. .; SAÑUDO, A.; RAMOS, L. R. Prescription of medicines for the aged: quality indicators, their instruments and measures as indispensable strategies in the health system. Research, Society and Development, [S. l.], v. 11, n. 2, p. e55311225942, 2022. DOI: 10.33448/rsd-v11i2.25942. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/25942. Acesso em: 19 nov. 2024.

Issue

Section

Review Article